Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.

Nozik-Grayck E, Suliman HB, Majka S, Albietz J, Van Rheen Z, Roush K, Stenmark KR.

Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L422-30. doi: 10.1152/ajplung.90293.2008. Epub 2008 Jul 3.

2.

Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling.

Nozik-Grayck E, Stenmark KR.

Adv Exp Med Biol. 2007;618:101-12. Review.

PMID:
18269191
3.

[Mechanisms of remodeling of pulmonary blood vessels in chronic hypoxia].

Herget J, Bíbová J, Novotná J.

Cesk Fysiol. 1999 Nov;48(4):179-84. Review. Czech.

PMID:
10748761
4.

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Stenmark KR, Fagan KA, Frid MG.

Circ Res. 2006 Sep 29;99(7):675-91. Review.

5.

Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?

Voelkel NF, Bogaard HJ, Al Husseini A, Farkas L, Gomez-Arroyo J, Natarajan R.

Antioxid Redox Signal. 2013 May 10;18(14):1810-7. doi: 10.1089/ars.2012.4828. Epub 2012 Sep 28. Review.

PMID:
22870869
6.

Antenatal hypoxia and pulmonary vascular function and remodeling.

Papamatheakis DG, Blood AB, Kim JH, Wilson SM.

Curr Vasc Pharmacol. 2013 Sep;11(5):616-40. Review.

7.
8.

The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR.

Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L229-52. doi: 10.1152/ajplung.00238.2014. Epub 2014 Nov 21. Review.

9.

The role of hypoxia in pulmonary vascular diseases: a perspective.

Voelkel NF, Mizuno S, Bogaard HJ.

Am J Physiol Lung Cell Mol Physiol. 2013 Apr 1;304(7):L457-65. doi: 10.1152/ajplung.00335.2012. Epub 2013 Feb 1. Review.

10.

Developmental Origins of Hypoxic Pulmonary Hypertension and Systemic Vascular Dysfunction: Evidence from Humans.

Sartori C, Rimoldi SF, Duplain H, Stuber T, Garcin S, Rexhaj E, Allemann Y, Scherrer U.

Adv Exp Med Biol. 2016;903:17-28. doi: 10.1007/978-1-4899-7678-9_2. Review.

PMID:
27343086
11.

Experimental and transgenic models of pulmonary hypertension.

West J, Hemnes A.

Compr Physiol. 2011 Apr;1(2):769-82. doi: 10.1002/cphy.c100003. Review.

PMID:
23737202

Supplemental Content

Support Center